Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

336.67
-2.0800-0.61%
Post-market: 336.67-0.00250.00%19:30 EDT
Volume:1.00M
Turnover:338.25M
Market Cap:9.97B
PE:42.26
High:341.35
Open:340.00
Low:335.50
Close:338.75
52wk High:382.54
52wk Low:158.08
Shares:29.60M
Float Shares:23.54M
Volume Ratio:4.00
T/O Rate:4.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.97
EPS(LYR):6.84
ROE:20.12%
ROA:9.37%
PB:7.33
PE(LYR):49.22

Loading ...

Stock Track | Krystal Biotech Soars 5.25% Intraday on Strong Q1 Earnings Beat and FDA RMAT Designation

Stock Track
·
May 04

Stock Track | Krystal Biotech Plummets 5.27% Intraday Despite Q1 Earnings Beat as Analysts Cut Estimates

Stock Track
·
May 04

Krystal Biotech Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Top Premarket Gainers

MT Newswires Live
·
May 04

S&P 500 Futures Fall In Premarket Trading; Victory Capital, Black Hills Lag

Dow Jones
·
May 04

Krystal Biotech Q1 revenue rises 32% on VYJUVEK growth

Reuters
·
May 04

Earnings Flash (KRYS) Krystal Biotech Posts Q1 EPS $1.83, vs. FactSet Est of $1.44

MT Newswires Live
·
May 04

Krystal Biotech 1Q26 net income climbs 56.58% to $55.9 million; revenue rises 32% to $116.4 million

Reuters
·
May 04

Stock Track | Krystal Biotech Soars 5.25% in Pre-Market on Strong Q1 Earnings and FDA RMAT Designation

Stock Track
·
May 04

BRIEF-Krystal Biotech Q1 Net Income USD 55.932 Million

Reuters
·
May 04

Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

THOMSON REUTERS
·
May 04

Krystal Biotech Q1 Operating Expenses USD 62.668 Million

THOMSON REUTERS
·
May 04

Krystal Biotech Q1 EPS USD 1.83

THOMSON REUTERS
·
May 04

Krystal Biotech Inc - on Track for KB803 and KB801 (Nk) Registrational Data Readouts in 2026

THOMSON REUTERS
·
May 04

What Krystal Biotech (KRYS)'s RMAT Win for KB707 in Lung Cancer Means For Shareholders

Simply Wall St.
·
May 04

Krystal Biotech presents at ASGCT annual meeting

Reuters
·
Apr 30

High Growth Tech Stocks To Watch In The US April 2026

Simply Wall St.
·
Apr 30

TD Cowen Sticks to Their Buy Rating for Krystal Biotech (KRYS)

TIPRANKS
·
Apr 24

Krystal Biotech (KRYS) Valuation Check As Shares Trade Near Suggested 5.2% Discount To Fair Value

Simply Wall St.
·
Apr 23

Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

GlobeNewswire
·
Apr 21